UBS Healthtech Summit 2023

Airdoc

Founded in September 2015, Airdoc is an AI-based medical device company with an advanced platform of AI empowered retina-based deep learning algorithms, and professional medical equipment design, R&D, registration and production teams, devotes to providing comprehensive and multi-faceted AI-based solutions for early screening and management on chronic diseases, and myopia prevention and control, which is a global market leader and pioneer in the field of AI-based retinal imaging. On November 5, 2021, Airdoc was successfully listed on the Stock Exchange (stock code: 2251) and became the first HK-listed medical AI company.

AMILI

BIO & ME is part of AMILI, Southeast Asia's first and only precision gut health company. Through BIO & ME, we provide access to important gut microbiome science and innovation.

We believe that 'Good Health Starts with Gut Health’ and have designed our gut health solutions to provide extensive and actionable insights to improve our customers’ gut microbiome. Our at-home gut health test (Singapore’s first) allows people to discover ways to improve brain health, boost immunity, or enhance metabolism. We also offer targeted probiotic formulations tailor-made for people living in Asia.

We're passionate about advancing human health and to positively impact the lives of millions of people
through microbiome science.

Chi Longevity

Chi Longevity is an expert-led centre of excellence providing a scientific-based proactive approach to ageing to guide individuals towards a younger, healthier self. A global leader in researching gerontology and internal medicine, Professor Andrea Maier (world renowned leader in Longevity Medicine) leads the medical suites’ programs and is supported by a team of healthcare specialists who curate a wholly personalised journey to promote vitality and prolong longevity. Health spans are optimised using cutting-edge diagnostics and multi-disciplinary interventions that target the ageing process.

The Chi Longevity journey begins with a multi-dimensional biological, clinical and digital diagnostic assessment to build an individual's unique health profile and highlight the precise hallmarks of biological ageing. A comprehensive evaluation of habits and preferences such as sleep, diet, stress levels, and exercise regimen is also conducted to supplement the analysis. Once the results are revealed, a personalised intervention plan to curate a longevity strategy is implemented, featuring evidence-based therapeutics, supplements and changes to lifestyle, social and physical environments.

The medical suites’ expert team of physicians, dieticians, psychologists and health coaches review and support the age-reversal program at every step of the way. Remote monitoring technologies are linked to an advanced digital health dashboard to enable up-to-the-minute recording of progress. Once the initial regimen is completed, progress is evaluated to observe changes in biomarkers, biological clocks, and the overall ageing process. After thorough analysis, Chi Longevity’s specialists devise a follow-up plan to sustain gains and promote further health goals.

Nalagenetics

Nalagenetics is a biotechnology company developing genetic interpretation kit and software. Nalagenetics aims to partner with labs to provide an affordable and actionable end-to-end genetic testing that is relevant to the local populations. The first use case is pharmacogenomics, genetic testing for personalized prescriptions in chronic conditions. The second is risk prediction using whole genome sequencing for chronic and neurodegenerative conditions. It has market presence in Southeast Asia and Europe.

Currently, Nalagenetics has received US$12.6m from Series A funding from global investors and was selected as the 1st place winner in the Mobility and Healthcare categories at the 2021 G20 Innovation League event.

NDR Medical Technology

NDR Medical Technology was founded in 2015 and developed the patented Automated Needle Targeting system (ANT) that can facilitate safe and accurate needle punctures to organs such as the lungs, kidney, pancreas, and spine. Integrating AI and robotics, we empower surgeons to conduct pioneer image-guided robotic procedures with improved accuracy, precision, and safety for patients.

Our first interventional robot (ANT-X) integrates C-arm fluoroscopy and AI software to assist clinicians in percutaneous needle placements and can be used in a wide range of procedures such as urology, neurology, and orthopedics. ANT-C is a smart lesion targeting system that AI uses CT-can images to automate lesion detection, needle path planning and needle targeting with unparalleled precision and accuracy. Applications include usages in pulmonology and hepatology. As a cut above the rest, our robots cost less than half of the current technology out in the market and can function without the need for external sensors.

With a renewed vision to lead AI-empowered interventional robotics, we strive to create revolutionary breakthroughs in the industry and transform the healthcare landscape.